approval
saveTRIJARDY XR (EMPAGLIFLOZIN) — FDA approval
community read0 votes
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025 · 342d ago
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 30, 2023 · 1067d ago
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022 · 1449d ago
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021 · 1938d ago
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 30, 2020 · 2162d ago
- approvalTRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalJan 27, 2020 · 2439d ago
same company · ±60 days · 6
- approvalSYNJARDY: JARDIANCE (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
- approvalSYNJARDY: JARDIANCE (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
- approval(empagliflozin + linagliptin): GLYXAMBI (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
- approval(empagliflozin + linagliptin): GLYXAMBI (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalJun 11, 2021
comments(0)
5-min edit window · permanent after that